Patients carrying variants in those regions of APC associated with an attenuated form of the disease were classed as one group (AFAP), patients having pathogenic variants within the MCR were classed as the most severe group (MCR-FAP) and all other patients were considered as “standard” polyposis patients (FAP). This evidence concerns the gene FAP and polyposis.